The research, conducted by a team affiliated with Minia University in Egypt, set out to answer a deceptively simple question: does the color of your quinoa matter when it comes to protecting your gut? The investigators compared ordinary white quinoa against a tri-color blend combining white, red, and black seeds in a rat model of indomethacin-induced gastric injury. Their rationale rested on well-documented chemistry. Red and black quinoa varieties typically carry substantially higher total phenolic content and greater radical-scavenging capacity than the pale traditional grain, thanks to pigments such as anthocyanins and betalains. The team hypothesized that this richer phytochemical arsenal would translate into measurably better gastroprotection.

Three signature compounds anchored the mechanistic case. Procyanidin B2, an oligomeric proanthocyanidin, is known to scavenge reactive oxygen species, inhibit lipid peroxidation, and suppress the NF-κB inflammatory master switch. Cinchonain IB, a complex flavanol derivative, has been associated with cytokine modulation and tissue repair. Kaempferol-3-O-rutinoside, a common flavonol, may downregulate inducible nitric oxide synthase and COX-2 while reinforcing the gastric mucus barrier. Because the density of these molecules varies dramatically between quinoa varieties, the researchers reasoned that a head-to-head dietary trial could reveal whether phytochemical diversity directly determines therapeutic potency.

The experimental design was deliberately food-based rather than extract-based. Thirty-six male Sprague Dawley rats were randomly assigned to six groups of six, following the ethical 3Rs principle to minimize animal use. Baked bread was prepared from either refined wheat flour, flour containing 40 percent white quinoa powder, or flour containing 40 percent tri-color quinoa powder, then ground and blended into a standard rodent diet at a 25:75 ratio. Daily portions were weighed and remnants collected to verify that every rat consumed a statistically uniform 21 to 23 grams of food per day, ensuring that any differences in outcome reflected the grain itself rather than unequal intake. After 21 days of feeding, injury was induced with a single oral dose of 30 milligrams per kilogram of indomethacin.

The results were striking. Indomethacin alone devastated the stomachs of control rats: gastric pH plummeted from 3.93 to 1.66, malondialdehyde, a lipid peroxidation marker of oxidative damage, surged from 0.15 to 0.23 nanomoles per gram, and reduced glutathione, the tissue’s primary endogenous antioxidant, collapsed from 1.80 to 0.71 milligrams per gram. Both quinoa diets pushed these values back toward baseline, but the tri-color blend consistently outperformed the white variety. Most notably, malondialdehyde in the tri-color group fell to 0.14 nanomoles per gram, essentially restoring oxidative balance, while glutathione recovered to 1.30 milligrams per gram, a 72 percent restoration compared with roughly 56 percent for white quinoa.

Inflammation told a parallel story. Cyclooxygenase activity more than doubled in the indomethacin-only controls, reaching 5.20 units per milligram, and nuclear NF-κB p65 climbed from 1.62 to 3.81 micrograms per milliliter. Tri-color quinoa supplementation cut COX activity to 2.96 and NF-κB to 2.11, a 45 percent reduction relative to injured controls, with white quinoa trailing slightly behind. Pepsin activity, a measure of the digestive enzyme that can chew through a compromised mucosa, followed the same pattern. The authors attribute these effects to the tri-color blend’s presumed abundance of anthocyanins, betalains, procyanidins, and cinchonains, compounds that literature links to glutathione regeneration and suppression of inflammatory signaling.

Under the microscope, the differences became visually unmistakable. Blinded pathologists, scoring tissue independently with strong agreement, graded necrosis, edema, and inflammation on a zero-to-three scale. Injured control rats scored 2.4 for necrosis, 2.8 for edema, and 2.6 for inflammation, reflecting extensive mucosal destruction, inflammatory infiltration, and submucosal swelling. White quinoa roughly halved those scores, but tri-color quinoa reduced necrosis to 0.4, edema to 0.6, and inflammation to 0.5, an 83 percent drop in mucosal necrosis and near-complete preservation of the gastric architecture. Body weight told the same tale: indomethacin-treated controls gained only 39 grams over the study, while quinoa-fed injured rats gained 42 to 44 grams, indicating that the grain blunted the drug’s systemic as well as local toll.

To probe mechanism, the team turned to molecular docking against human crystal structures of the gastric proton pump Atp4a, COX-2, and NF-κB. Procyanidin B2 bound the proton pump with an affinity of minus 8.9 kilocalories per mole, outperforming the co-crystallized reference ligand and offering a theoretical basis for quinoa acting as a natural acid-secretion moderator. Cinchonain IB delivered the standout result at NF-κB, binding at minus 8.2 kilocalories per mole through hydrogen bonding with Lys417 and hydrophobic contact with Phe439, a mode resembling synthetic NF-κB inhibitors. The authors also note that baking may not destroy these compounds: internal crumb temperatures during standard baking hover around 95 to 98 degrees Celsius, and heat can even release bound phenolics into more bioaccessible forms, which helps explain why a bread-based intervention worked.

The study also raised gastric pH in treated animals, from 1.66 to 2.10 in the tri-color group, possibly through the buffering action of quinoa’s organic acids such as malate and citrate, and boosted mucin production, thickening the physical mucus barrier that stands between acid and epithelium. Together with the antioxidant and anti-inflammatory data, these findings sketch a coherent, multi-front defense: quinoa compounds simultaneously neutralize radicals, calm inflammatory transcription, buffer luminal acidity, and reinforce the mucus lining. The authors caution, however, that they could not perform chromatographic profiling of their specific extracts because the batch was exhausted, so attribution to individual compounds remains literature-based and suggestive rather than definitive.

The limitations are real. Only male rats were studied, leaving sex-specific responses unexplored; a single high-dose time point cannot capture the dynamics of long-term human consumption; and no human trial data exist yet. Still, the central message is compelling and unusually practical: the pigmented seeds of a climate-resilient Andean pseudocereal, eaten as ordinary bread, outprotected their paler counterpart against one of the most common drug side effects in medicine. If future chromatographic, dose-ranging, and clinical studies confirm the effect, tri-color quinoa could move from trendy salad topping to evidence-backed dietary ally for the millions of people who need daily NSAID relief but cannot afford to sacrifice their stomachs along the way.

Subject of Research: Gastroprotective effects of white and tri-color quinoa against NSAID-induced gastric injury

Article Title: Comparative Evaluation of White Quinoa and Tri‐Color Quinoa on Indomethacin‐Induced Gastrointestinal Damage

Article References: Alqahtani, N. S., Hassan, H. M., Mohamed, H. M., Gazaly, F. M., & Sadeek, R. A. (2026). Comparative Evaluation of White Quinoa and Tri‐Color Quinoa on Indomethacin‐Induced Gastrointestinal Damage. Food Science & Nutrition, 14(10), Article e72418. https://doi.org/10.1002/fsn3.72418

Image Credits: AI Generated

DOI: 10.1002/fsn3.72418

Keywords: quinoa, NSAIDs, indomethacin, gastric ulcer, gastroprotection, polyphenols, procyanidin B2, cinchonain IB, NF-κB, oxidative stress, functional foods, molecular docking

The research team, led by Emine Merve Ekici together with Pınar Göbel and Neslihan Arslan, set out to answer a deceptively simple question: is nutritional risk associated with how satisfied older adults feel about their lives? To do this, they turned to a web-based cross-sectional survey, recruiting 779 community-dwelling adults aged 65 and older. The choice of a community-based sample matters. Rather than studying hospitalized patients or nursing home residents, the investigators focused on older people living independently, the vast majority of the aging population and the group in whom early signs of nutritional decline are most easily overlooked.

Measuring nutritional risk in this population is not straightforward. Standard screening tools designed for younger adults often miss the subtle shifts in appetite, chewing and swallowing ability, meal patterns, and food intake that characterize malnutrition risk in old age. The researchers therefore used the Turkish version of the Nutritional Form for the Elderly, known as NUFFE-TR. This twelve-item instrument was developed specifically for geriatric populations and covers domains such as body mass index, weight change, appetite, eating difficulties, number of full meals per day, food intake frequency, and fluid consumption. Each item contributes to a total score ranging from 0 to 24, with higher scores signaling greater malnutrition risk. The Turkish adaptation has made the tool accessible for large-scale research in a country with a rapidly aging population.

Life satisfaction, the second key variable, was assessed with the twenty-item Life Satisfaction Scale, which produces scores from 0 to 20, where higher values indicate greater satisfaction with life. Unlike momentary happiness, life satisfaction reflects a stable, cognitive evaluation of how one’s life is going overall, making it a central concept in gerontology and in the broader science of well-being. By pairing a geriatric-specific nutritional screen with a validated life satisfaction measure, the study could test whether the two constructs move together in a predictable way.

They do, and the association is substantial. The researchers found a negative Spearman correlation of −0.47 between NUFFE-TR scores and life satisfaction, a moderate-to-strong relationship by conventional statistical standards, and one that was highly significant with a p-value below 0.001. In plain terms, the more nutritional risk an older adult carried, the less satisfied they tended to be with their life. Correlation alone, however, can be misleading, since older people with poorer health, lower income, or fewer social connections might simultaneously eat worse and feel worse, creating a spurious link.

To address that concern, the team built a multiple linear regression model that included age, body mass index, and nutritional risk as predictors of life satisfaction. Even in this adjusted model, higher nutritional risk remained an independent predictor of lower life satisfaction, with a standardized beta of −0.341 and a 95 percent confidence interval spanning −0.438 to −0.294. The model as a whole explained 12.7 percent of the variance in life satisfaction, a modest but meaningful share for a psychological outcome that is shaped by countless factors, from health status and income to relationships and personality. The fact that nutrition contributed independently suggests the association is not simply a proxy for being older or heavier.

The biological and behavioral logic behind such a link is plausible. Malnutrition in older adults is associated with sarcopenia, frailty, weakened immunity, slower wound healing, and higher rates of hospitalization, all of which can restrict independence and daily functioning. Nutritional deficiencies, including inadequate protein, vitamins, and micronutrients, may also affect mood and cognition through inflammatory pathways and neurotransmitter synthesis. Conversely, the relationship may run in the other direction: older adults who feel dissatisfied, lonely, or depressed may lose appetite and motivation to cook and eat, gradually sliding into nutritional risk. The cross-sectional design of this study cannot disentangle these possibilities, and the authors are explicit that longitudinal research is needed to clarify causality.

That caveat is worth emphasizing, because it defines what the study can and cannot claim. A cross-sectional survey captures a single moment in time, so it can establish that nutritional risk and low life satisfaction co-occur, but not which comes first. The web-based format also raises questions about who was reached: older adults comfortable completing online questionnaires may differ systematically from those who are not, potentially limiting generalizability. The sample of 779 participants is nonetheless large for studies of this kind, and the use of validated instruments with defined score ranges strengthens confidence in the measurements themselves. The study received ethics approval from the University of Health Sciences Gülhane Scientific Research Ethics Committee and was conducted under the Declaration of Helsinki with written informed consent from all participants.

Why should the broader public care about a statistical beta coefficient from a Turkish survey? Because the implications are practical and potentially far-reaching. Populations worldwide are aging at unprecedented speed, and malnutrition among community-dwelling older adults is widely recognized as underdiagnosed, since it often develops quietly through reduced appetite, dental problems, social isolation, and chronic disease. If nutritional risk is genuinely entangled with psychological well-being, then a simple twelve-item questionnaire administered during routine primary care visits could flag not only people at risk of physical decline but also those whose overall quality of life may be quietly deteriorating. The authors argue that incorporating nutritional screening into geriatric care could support early detection and promote healthy aging, a low-cost intervention compared with treating the downstream consequences of malnutrition.

The study also contributes a methodological resource: by applying the NUFFE-TR scale in a large community sample and linking it to a well-being outcome, it demonstrates the feasibility of integrating geriatric nutrition screening into psychosocial research. Future work, the researchers suggest, should follow older adults over time to determine whether worsening nutritional status precedes declining life satisfaction, whether interventions that improve diet also lift well-being, and whether the relationship varies across cultures and care settings. For now, the message is a compelling one: in later life, the quality of the diet and the quality of the lived experience appear to travel together, and paying attention to what older adults eat may be one of the simplest windows into how well they feel their lives are going.

Subject of Research: The association between nutritional risk and life satisfaction in community-dwelling older adults

Article Title: Nutritional risk and life satisfaction in older adults: a cross-sectional analysis using the NUFFE-TR scale

Article References: Ekici, E. M., Göbel, P., & Arslan, N. (2026). Nutritional risk and life satisfaction in older adults: a cross-sectional analysis using the NUFFE-TR scale. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08343-4

Image Credits: AI Generated

DOI: 10.1186/s12877-026-08343-4

Keywords: geriatric nutrition, nutritional risk, life satisfaction, older adults, NUFFE-TR, malnutrition, healthy aging, well-being, cross-sectional study, psychosocial health, BMC Geriatrics, Nutritional

The distinction between macronutrients and micronutrients is central to understanding how soil condition translates into human nutrition. Macronutrients such as nitrogen, phosphorus, potassium, calcium, and magnesium are required in relatively large amounts and are the traditional focus of fertilizer programs. Micronutrients, by contrast, are needed in trace quantities but perform indispensable roles in human physiology. The source evidence identifies seventeen micronutrients relevant to human health, including iron, zinc, iodine, selenium, copper, molybdenum, manganese, and fluoride. Deficiencies of iron and iodine alone can produce anemia, impaired cognitive development, and thyroid disorders, conditions that remain widespread in regions where soils are degraded and diets lack diversity. Because plants acquire these elements from the soil solution, the nutritional quality of food is ultimately a reflection of what the soil can supply.

This pathway helps explain why malnutrition, understood as a deficiency of essential nutrients even when calories are sufficient, may be a larger global problem than undernutrition in terms of the vulnerable population affected. A field can produce abundant cereal grain on a degraded soil, yet that grain may carry lower concentrations of zinc or iron than grain grown on a healthier counterpart. The result is a paradox in which food availability improves while nutritional adequacy stagnates or declines. Addressing this paradox requires attention to the soil processes that govern micronutrient availability, including pH regulation, organic matter dynamics, and the activity of mycorrhizal fungi and other soil organisms that mobilize otherwise inaccessible elements.

The soil microbiome adds another dimension to this nexus. Healthy soils with robust organic matter content host diverse microbial communities that suppress soil-borne pathogens and can reduce the incidence of mycotoxins produced by fungal contaminants. Reduced disease pressure means fewer fungicide and insecticide applications, which in turn lowers pesticide residues in harvested food. There is also emerging interest in the possibility that the soil microbiome influences the human gut microbiome through the food chain, since the microbial and biochemical profile of produce reflects the environment in which it was grown. While this area of research is still developing, it reinforces the One Health premise that the health of soil, plants, and people is indivisible rather than merely analogous.

Clay mineralogy offers a concrete example of how inherent soil properties shape management options. Soils dominated by 1:1 clays, such as kaolinite, have low cation exchange capacity and limited capacity to hold nutrients, whereas 2:1 clays such as smectites have high charge density and large surface areas. Swelling and shrinking behavior in 2:1 clays affects aggregation, aeration, and root penetrability, while low-activity clays in many tropical soils leave smallholder farmers with little inherent nutrient reserve. The evidence notes that low nutrient reserves resulting from low charge density and low external inputs are a primary cause of low yields among resource-poor farmers in the global south. Any strategy for improving crop health in these regions must therefore combine organic and mineral inputs in ways that compensate for inherent mineralogical constraints.

Water dynamics are inseparable from these considerations. The capacity of a soil to hold plant-available water, sometimes described as green water stored in the root zone, determines how crops weather dry periods between rainfall events. Organic matter improves this capacity, as does good aggregation and minimal compaction. Conversely, degraded soils shed water rapidly as runoff, exposing crops to both drought stress during dry spells and inundation during intense storms. The coupled cycling of carbon, nitrogen, water, phosphorus, and sulfur must remain in balance; perturbing one cycle through land misuse inevitably disturbs the others, with consequences for nutrient leaching, greenhouse gas emissions, and water quality downstream.

The four components of soil health identified in the evidence, namely physical, chemical, biological, and ecological, provide a useful framework for diagnosis. Physical health encompasses structure, aggregation, porosity, and resistance to erosion by water and wind. Chemical health covers nutrient reserves, exchange capacity, and the absence of toxicities. Biological health reflects the abundance and diversity of organisms ranging from bacteria and fungi to earthworms. Ecological health describes how these elements function together to deliver ecosystem services. Because most of these components respond to soil organic matter, management practices that build organic matter tend to improve all four dimensions simultaneously, which is why organic matter is often treated as a master indicator of soil condition.

Regenerative agriculture and agroecological principles offer practical routes to this goal. Practices such as cover cropping, diversified rotations, reduced or no tillage, integration of livestock, mulching with crop residues, and agroforestry all contribute biomass carbon to the soil while protecting it from erosion. Leguminous cover crops add biologically fixed nitrogen, reducing dependence on synthetic fertilizers whose production and overuse carry environmental costs. Diverse rotations break pest and disease cycles, lowering pesticide requirements. These practices align with the four components of crop health proposed by Vega and colleagues, namely usefulness, adversities, safety, and autonomy, since they enhance productive usefulness while reducing adversities, improving safety, and increasing farmer autonomy from costly external inputs.

The salutogenic orientation embedded in this framework is worth emphasizing. Rather than defining crop health merely as the absence of pests or deficiencies, a salutogenic perspective asks what factors actively generate and sustain health. Meaningfulness, comprehensiveness, and manageability, borrowed from models of human wellbeing, translate into farming systems that farmers understand, can manage with available resources, and find worthwhile. This has implications for extension and policy: recommendations that ignore farmers’ economic realities and knowledge systems are unlikely to improve crop health at scale, no matter how sound the underlying agronomy.

Policy instruments also have a role. The evidence argues that soil health legislation at state, national, continental, and international levels should explicitly address crop health management and the research and outreach needed to advance it. Such policies should be pro-nature, pro-agriculture, and pro-farmer simultaneously, recognizing that these objectives are complementary rather than competing. Where farmers are compensated for building soil carbon, restoring biodiversity, or improving water quality, the private incentives of individual land managers align with the public benefits of ecosystem services. Conversely, policies that reward yield alone can encourage practices that mine soil fertility and externalize environmental costs.

The regional dimensions of the challenge deserve attention. Sub-Saharan Africa, South Asia, and Latin America carry a disproportionate burden of undernutrition, malnutrition, and soil degradation, and they are also regions where smallholder farming dominates. In these settings, even modest improvements in soil organic matter and nutrient supply can produce meaningful gains in yield stability and nutritional quality. Because smallholders often lack access to irrigation and purchased inputs, practices that rely on locally generated biomass and biological nitrogen fixation are particularly appropriate. At the same time, these regions face intensifying pressure from climate change, which raises the value of soil-based water buffering and carbon sequestration as adaptation and mitigation strategies.

Food safety completes the picture. Crops grown in clean environments with minimal agrochemical residues protect consumers from chronic exposure to harmful compounds, while suppression of pathogens and mycotoxins in healthy soils reduces acute risks. Safe, nutritious food supports not only physical health but also mental health and overall wellbeing, according to the evidence reviewed. The quality of the surrounding environment, including water, air, microclimate, and above- and below-ground biodiversity, is improved in parallel, so the benefits of crop health management extend well beyond the field boundary.

Taken together, these threads support a coherent conclusion: crop health is not a narrow agronomic metric but a nexus concept linking soil processes, food composition, environmental quality, and human wellbeing. Managing it well requires treating the soil as a living system whose physical, chemical, biological, and ecological functions can be built up or squandered through everyday decisions. It requires policies that recognize farmers as stewards of ecosystem services, research programs that integrate soil science with human nutrition, and farming systems grounded in ecological principles. The slogan that healthy soils produce healthy crops and healthy people is more than rhetoric; it summarizes a causal chain that science is increasingly able to trace, and that agricultural policy would do well to follow.

Subject of Research: Crop health management for food and nutritional security and soil health

Article Title: Crop health management for food and nutritional security and soil health

Article References: Lal, R. (2026). Crop health management for food and nutritional security and soil health. Crop Health, 4(1), Article 22. https://doi.org/10.1007/s44297-026-00083-6

Image Credits: AI Generated

DOI: 10.1007/s44297-026-00083-6

Keywords: Crop, health, management, food, nutritional, security, soil, scientific research

The appeal of mEVs begins with their membrane. Cholesterol, sphingomyelin and ceramides help create a relatively robust lipid bilayer that shields internal cargo from environmental damage. Studies summarized in the review indicate that milk vesicles can remain intact under simulated gastrointestinal conditions and protect RNA from digestive enzymes such as ribonucleases. After oral administration, vesicles may interact with intestinal epithelial cells through endocytosis, membrane fusion or receptor-mediated uptake, allowing their contents to enter recipient cells. Some experimental work also suggests that milk vesicles or their cargo can reach tissues beyond the gut, including the brain. This possibility is particularly important because the blood-brain barrier restricts many therapeutic molecules. However, crossing that barrier in animal or cellular models does not establish effective delivery in people. Biodistribution depends on vesicle size, surface proteins, cargo, dose, species of origin, processing conditions and administration route. The review therefore treats gastrointestinal stability and barrier transport as promising properties, not guarantees of therapeutic performance.

Milk vesicles are not a single uniform material. The broader extracellular-vesicle population includes exosomes, microvesicles and apoptotic bodies, which differ in size and how they form. Exosomes develop inside multivesicular bodies when endosomal membranes bud inward to create intraluminal vesicles; multivesicular bodies can then fuse with the plasma membrane and release them. Microvesicles form by outward budding of the cell surface, involving calcium-dependent cytoskeletal changes and redistribution of membrane lipids. In milk, the vesicle population is shaped by the animal species, lactation stage, maternal physiology, diet and health status. Bovine, human, goat, camel, porcine and equine milk can therefore contain different mixtures of proteins and regulatory RNAs. Commonly measured surface or intracellular markers include CD9, CD63, CD81, TSG101 and Alix, but marker detection alone does not define purity or biological function. The review calls for multi-method characterization that combines particle sizing, microscopy, protein analysis, RNA profiling and functional testing.

Obtaining clean vesicles from milk is technically difficult because milk is a complex mixture containing casein micelles, soluble proteins, fat globules and other particles with overlapping physical properties. Differential ultracentrifugation remains widely used, separating material according to size and density, but it can be slow and may promote aggregation or structural damage. Ultrafiltration and polyethylene-glycol precipitation are easier to scale, yet they can recover non-vesicular contaminants. Size-exclusion chromatography separates particles by hydrodynamic size and is often combined with other methods to improve purity. Immunoaffinity capture can select vesicles carrying particular surface markers, although it may reduce recovery and exclude biologically relevant subpopulations. Emerging microfluidic and immunomagnetic systems could enable automated processing of small volumes, while tangential-flow filtration combined with chromatography offers a possible route toward larger-scale production. Across all approaches, researchers need consistent measurements of particle number, size distribution, morphology, membrane integrity, cargo and contaminating milk proteins.

As delivery systems, mEVs could carry molecules that otherwise degrade quickly or dissolve poorly. The review describes experimental loading with polyphenols such as curcumin, resveratrol, quercetin and epigallocatechin gallate, as well as chemotherapeutic compounds including paclitaxel and doxorubicin. Encapsulation may improve aqueous dispersal, protect cargo during digestion and increase contact with intestinal tissues. Vesicles have also been investigated for transporting small interfering RNA, microRNA, messenger RNA, peptides and proteins. In principle, this creates a dual-purpose platform: the vesicle’s native cargo may influence recipient cells, while an added therapeutic molecule supplies a designed activity. Surface engineering could further attach targeting ligands or alter tissue distribution. Yet loading is not straightforward. Passive incubation, membrane permeabilization and other approaches can produce different encapsulation efficiencies and may damage the vesicle. A useful product would require reproducible cargo content, predictable release kinetics and evidence that the loaded molecule reaches the intended tissue at a clinically meaningful dose.

The biological effects reported across models are broad but uneven. In intestinal systems, milk vesicles have been associated with stronger tight junctions, including proteins such as ZO-1, occludin and claudin-1, and with reduced inflammatory signaling. MicroRNAs including miR-148a, miR-21, miR-30a and miR-146b may influence pathways involving NF-κB, Toll-like receptors, DNA methylation and the NLRP3 inflammasome. In cell and animal studies, these mechanisms have been linked to lower inflammatory cytokines, improved barrier function and protection from oxidative stress. Other experiments report effects on macrophage polarization, with some mEV preparations encouraging an anti-inflammatory state. Researchers have also examined bone, liver, heart, lung and pancreatic applications. Milk vesicles have been tested in models of colitis, metabolic dysfunction, fibrosis, osteoporosis, vascular injury and pulmonary inflammation. These findings suggest multiple possible mechanisms, including direct cargo transfer, modulation of gut microbiota and communication along the gut-liver or gut-heart axes, but they do not demonstrate that drinking milk or consuming an unstandardized vesicle preparation treats disease.

Several findings illustrate why careful interpretation is essential. In mice, orally administered milk vesicles have been reported to cross the blood-brain barrier, increase hippocampal dendritic complexity and improve selected cognitive or motor outcomes. Other studies have found changes in microglial DNA-methylation machinery or neuronal survival in cellular models. At the same time, neurological results vary with dose, species, metabolic context and experimental design. A separate line of research has raised hypotheses about interactions between milk exosomes and excessive galactose exposure, while other work found that aging had stronger effects on rat brain lipid profiles and cognition than an extracellular-vesicle-rich supplement. Lung studies likewise include contrasting observations: some mEV preparations protect epithelial barriers or deliver anti-fibrotic compounds, whereas bovine vesicles increased inflammatory macrophage polarization in mice exposed to agricultural dust. In cancer research, vesicles have delivered drugs and gene regulators to tumour models, but one study reported that oral bovine milk vesicles slowed primary-tumour growth while accelerating metastasis. Such results make clear that mEVs are biologically active, context-dependent materials rather than universally beneficial particles.

Translation will depend on proving safety and manufacturing consistency as much as on demonstrating biological activity. Milk origin does not automatically eliminate risk. Preparations can retain caseins, beta-lactoglobulin and other proteins that may trigger reactions in people with milk allergy. Repeated exposure also requires assessment of immune activation, liver and kidney function, oxidative stress, tissue distribution and delayed toxicity. Thermal processing can reduce vesicle yield or disrupt structure, complicating the relationship between fresh milk, pasteurized products and purified formulations. Regulators will also need to determine whether a given product is a food, supplement, biologic, nanomedicine or combination product, since each category carries different requirements. The review points toward standardized isolation protocols, validated vesicle markers, sensitive contaminant testing, single-vesicle and multi-omic analysis, stable storage methods and Good Manufacturing Practice production. Human pharmacokinetic and clinical studies will be decisive. For now, milk-derived extracellular vesicles represent a promising natural nanocarrier platform whose future rests on converting intriguing laboratory observations into reproducible, well-controlled and demonstrably safe interventions.

A further advantage of mEVs is that their value may extend beyond their role as passive containers. Their membranes carry naturally occurring adhesion molecules, tetraspanins and transport-related components that can influence how vesicles are recognized, internalized and distributed. This biological interface distinguishes them from liposomes and polymeric nanoparticles, whose composition can be tuned with considerable precision but generally requires deliberate surface engineering to achieve comparable interactions with cells. The contrast is not absolute: synthetic systems offer stronger control over particle uniformity, drug loading and release kinetics, while mEVs offer a more physiologically integrated membrane and a potentially favorable safety profile. Hybrid designs that combine EV membranes with synthetic cores therefore represent one strategy for balancing biological compatibility with manufacturing control.

The native cargo also complicates how mEV products should be designed and evaluated. A preparation intended to deliver an added drug or RNA may simultaneously contain endogenous proteins, lipids, microRNAs and metabolites capable of altering immune or metabolic responses. Those constituents could contribute to efficacy, but they could also vary with animal species, lactation conditions, feed, health status and processing history. Consequently, measuring total particle concentration is insufficient for comparing products. Functional potency assays will need to establish whether a defined preparation produces a reproducible cellular response, while molecular profiling can help identify which cargo components are retained, enriched or lost during isolation and loading. This is especially important when the desired activity depends on cooperation between the vesicle membrane and its internal contents rather than on a single therapeutic molecule.

Manufacturing scale is promising but should not be confused with readiness for routine clinical use. Milk provides a comparatively accessible starting material, and the review describes ultracentrifugation, size-exclusion chromatography and precipitation methods as established approaches, with tangential-flow and related technologies offering routes toward process intensification. At larger scale, however, purification must preserve membrane integrity while removing abundant non-vesicular milk constituents and maintaining consistent particle and cargo characteristics. The field has reached early translational milestones, including a reported first clinical trial involving mEV-based formulations for RNA therapeutics and anticancer agents, but such studies are only an initial test of feasibility. Results from carefully controlled human investigations will need to define dose, absorption, biodistribution, immune effects and clinically meaningful benefit before the farm-to-pharmacy concept can support approved interventions.

Subject of Research: Milk-derived extracellular vesicles as nutritional and therapeutic nanocarriers

Article Title: Milk-derived extracellular vesicles: nutritional significance, nano-delivery potential, and emerging therapeutic applications – an updated review

Article References: Wang, S., Shaukat, A., Al-Rasheed, M., Tareen, A. M., Arain, M. A., & Luo, C. (2026). Milk-derived extracellular vesicles: nutritional significance, nano-delivery potential, and emerging therapeutic applications – an updated review. Food Science of Animal Resources, 46(1), Article 96. https://doi.org/10.1007/s44463-026-00104-6

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00104-6

Keywords: extracellular vesicles, milk nanocarriers, nutraceutical delivery, drug delivery, microRNAs, precision medicine, gut health, nanomedicine, Milk-derived, extracellular, vesicles, nutritional